The novel approach of the medication represents a significant advance in the management of type 2 diabetes. Unlike existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide156729.jiliblog.com/98417352/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment